Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
TCRT Alaunos Therapeutics
0.735+0.023+3.23%
Trading Session
02/02 14:00 ET
High
0.774
Open
0.766
Turnover
325.83K
Low
0.705
Pre Close
0.712
Volume
445.89K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
FY2022 Earnings Forecast for Alaunos Therapeutics, Inc. Issued By Cantor Fitzgerald (NASDAQ:TCRT)
Alaunos Therapeutics, Inc. (NASDAQ:TCRT – Get Rating) – Research analysts at Cantor Fitzgerald raised their FY2022 EPS estimates for Alaunos Therapeutics in a research note issued on Tuesday, Janu
Alaunos Therapeutics Expects Cash to Fund Operations Into Q4 2023
Alaunos Therapeutics Highlights Strategic Priorities and Anticipated Portfolio Milestones for 2023
Genmab A/S (NASDAQ:GMAB) and Alaunos Therapeutics (NASDAQ:TCRT) Financial Survey
Alaunos Therapeutics (NASDAQ:TCRT – Get Rating) and Genmab A/S (NASDAQ:GMAB – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two companies based on
Welch Group LLC Takes Position in Alaunos Therapeutics, Inc. (NASDAQ:TCRT)
Welch Group LLC purchased a new stake in shares of Alaunos Therapeutics, Inc. (NASDAQ:TCRT – Get Rating) during the third quarter, according to its most recent Form 13F filing with the Securities &
12 Health Care Stocks Moving In Monday's After-Market Session
GainersEargo (NASDAQ:EAR) shares moved upwards by 18.7% to $0.73 during Monday's after-market session. Trading volume for this security closed at 1.2 million, accounting for 98.1% of its average full-
Trade Alert: The Independent Director Of Alaunos Therapeutics, Inc. (NASDAQ:TCRT), Jaime Vieser, Has Just Spent US$813k Buying 117% More Shares
Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Director Robert W. Postma Buys 750,000 Shares
Alaunos Therapeutics, Inc. (NASDAQ:TCRT – Get Rating) Director Robert W. Postma bought 750,000 shares of the business's stock in a transaction on Tuesday, November 29th. The shares were acquired at a
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersSCWorx (NASDAQ:WORX) shares moved upwards by 15.2% to $0.53 during Thursday's after-market session. The company's market cap stands at $6.8 million. Allarity Therapeutics (NASDAQ:ALLR) shares i
Alaunos Therapeutics Expects $15.7 Million in Gross Proceeds From Common Shares Offering
10:40 AM EST, 11/29/2022 (MT Newswires) -- Alaunos Therapeutics (TCRT) said Tuesday it has priced its underwritten offering of about 24.2 million common shares for gross proceeds of roughly $15.7 mill
Company Overview
More
ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of immuno-oncology platforms that leverage cell- and gene-based therapies to treat patients with cancer. Its pipeline includes Sleeping Beauty TCR-T Targeting neoantigens; Ad-RTS-hlL-12 + veledimex; and Sleeping Beauty CAR-T. The company was founded on September 9, 2003 and is headquartered in Boston, MA.
CEO： Mr. Kevin S. Boyle
Market： NASDAQ
Listing Date： 09/22/2006
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet